Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03290430 · ClinicalTrials.gov registry record · Early Phase 1
End Nicotine Dependence Clinic
A Early Phase 1 study of Smoking Cessation, sponsored by Case Comprehensive Cancer Center.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 56
- Enrollment target
- 1
- Study location
NCT03290430 is a Early Phase 1 study of Smoking Cessation that has completed, run by Case Comprehensive Cancer Center. The registered enrollment target is 56 participants, below the 474-participant average among 188 other Smoking Cessation trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03290430, a Early Phase 1 study of Smoking Cessation, has completed, sponsored by Case Comprehensive Cancer Center.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 56 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to study a smoking cessation program for adult smokers in Northeast Ohio. The study will also look at how different people respond to the program.
Conditions Studied
Interventions
- BEHAVIORAL Individual Counseling
- BEHAVIORAL Group Counseling
- BEHAVIORAL Phone Counseling
- BEHAVIORAL Video Counseling
- BEHAVIORAL Texting support
Study Locations (1)
Ohio
- Case Western Reserve University, Case Comprehensive Cancer Center - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2018-01-09 |
| Est. Completion | 2020-01-06 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03290430
The ClinicalTrials.gov registry entry for NCT03290430 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 474-participant average among 188 other Smoking Cessation trials with a reported enrollment target (88% lower). The listed sponsor is Case Comprehensive Cancer Center, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Smoking Cessation appearing as the primary indexed condition, and to 5 interventions - of which Individual Counseling is the first listed.
NCT03290430 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT03290430 about?
NCT03290430 is a clinical study titled "End Nicotine Dependence Clinic". The purpose of this research is to study a smoking cessation program for adult smokers in Northeast Ohio. The study will also look at how different people respond to the program.
What is the current status of trial NCT03290430?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 56 participants. The study started on 2018-01-09. Estimated completion is 2020-01-06.
What conditions does trial NCT03290430 study?
This clinical trial studies the following conditions: Smoking Cessation.
What interventions are being tested in trial NCT03290430?
The interventions under investigation include: Individual Counseling (BEHAVIORAL), Group Counseling (BEHAVIORAL), Phone Counseling (BEHAVIORAL), Video Counseling (BEHAVIORAL), Texting support (BEHAVIORAL).
Who is sponsoring clinical trial NCT03290430?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03290430 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking Cessation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Smoking Cessation Intervention During Low Dose CT (LDCT) Screening for Lung Cancer
ACTIVE NOT RECRUITING · Early Phase 1
-
Smoking Cessation Treatment for Head & Neck Cancer Patients
ACTIVE NOT RECRUITING · Early Phase 1
-
Hollings Cancer Center Varenicline Sampling Study
COMPLETED · Early Phase 1
-
Applying mHealth to Tobacco-related Health Disparities
COMPLETED · Early Phase 1
-
Ketamine and Motivational Enhancement Therapy for the Treatment of Tobacco Use Disorder
COMPLETED · Early Phase 1
-
Smoking by IV Pulsed Nicotine
COMPLETED · Early Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.